AN2227 | |
---|---|
Uniprot | Q5BB53 |
Length | 838 |
Bioinformatic-based prediction
Signal peptide | |
---|---|
SignalP | No |
Phobius | No |
Uniprot annotation with experimental evidence | NA |
Transmembrane domain | |
TMHMM | No |
Phobius | No |
Uniprot annotation with experimental evidence | NA |
GPI anchor | |
bigPI | No |
PredGPI | No |
Uniprot annotation with experimental evidence | NA |
Subcellular localization | |
WolF Psort1 | C |
Protcomp1 | C |
TargetP1 | _ |
Uniprot annotation with experimental evidence | NA |
1Following letter codes were used for different subcellular localization predictions from WoLF PSORT, Protcomp and TargetP:
P - Plasma membrane, E - Extracellular, S - Secretory pathway, M - Mitochondrial, ER - Endoplasmic reticulum, C- Cytoplasmic/Cytosol, L- Lysosomal,
G - Golgi apparatus, N - Nuclear, V - Vacuolar, R - Peroxisomal, CN - Cytosol and Nucleus, CK - Cytoskeleton, CM - Cytosol and Mitochondria, _ - Other
Endoplasmic reticulum (ER) retention signal | |
---|---|
PS SCAN | No |
Abundance of Antigenic Regions (AAR) | |
---|---|
Kolaskar & Tongaonkar | 22.649 |
BepiPred | 46.5555555556 |
Annotation | |
---|---|
Gene Ontology (GO) | GO:0009251, GO:0008422 glucan catabolic process (BP), beta-glucosidase activity (MF) |
CAZy | GH3 |
Pfam | PF01915.21, PF00933.20, PF14310.5, PF07691.11 Glycosyl hydrolase family 3 C-terminal domain, Glycosyl hydrolase family 3 N terminal domain, Fibronectin type III-like domain, PA14 domain |
TIGRFAM | NA NA |
SFLD | NA NA |
SMARTS | NA NA |
CDD | NA NA |
Prosite Profiles | NA NA |
Prosite Patterns | PS00775 Glycosyl hydrolases family 3 active site. |
SUPERFAMILY | SSF51445,SSF52279,SSF52279,SSF56988 ,,, |
PRINTS | PR00133,PR00133,PR00133,PR00133,PR00133 Glycosyl hydrolase family 3 signature,Glycosyl hydrolase family 3 signature,Glycosyl hydrolase family 3 signature,Glycosyl hydrolase family 3 signature,Glycosyl hydrolase family 3 signature |
COILS | NA NA |
MobiDB lite | NA NA |
Similar drug target from DrugBank
Drug target ID | Blastp e-value | Potential drugs |
---|---|---|
P40406 | 3.26E-13 | DB08357 |